Please login to the form below

Not currently logged in
Email:
Password:

umeclidinium

This page shows the latest umeclidinium news and features for those working in and with pharma, biotech and healthcare.

Novartis strengthens case for its combination asthma drug

Novartis strengthens case for its combination asthma drug

However, it was still able to establish its next-generation of respiratory products – this includes Trelegy (vilanterol/umeclidinium/ fluticasone furoate), which brought in £139 in  Q3 and Nucala (mepolizumab), which brought

Latest news

More from news
Approximately 9 fully matching, plus 53 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics